334 related articles for article (PubMed ID: 23325367)
1. Recent advances in the development of 1,8-naphthalimide based DNA targeting binders, anticancer and fluorescent cellular imaging agents.
Banerjee S; Veale EB; Phelan CM; Murphy SA; Tocci GM; Gillespie LJ; Frimannsson DO; Kelly JM; Gunnlaugsson T
Chem Soc Rev; 2013 Feb; 42(4):1601-18. PubMed ID: 23325367
[TBL] [Abstract][Full Text] [Related]
2. Naphthalimide derivatives with therapeutic characteristics: a patent review.
Kamal A; Bolla NR; Srikanth PS; Srivastava AK
Expert Opin Ther Pat; 2013 Mar; 23(3):299-317. PubMed ID: 23369185
[TBL] [Abstract][Full Text] [Related]
3. DNA binding and anticancer activity of naphthalimides with 4-hydroxyl-alkylamine side chains at different lengths.
Wang K; Wang Y; Yan X; Chen H; Ma G; Zhang P; Li J; Li X; Zhang J
Bioorg Med Chem Lett; 2012 Jan; 22(2):937-41. PubMed ID: 22200595
[TBL] [Abstract][Full Text] [Related]
4. Highly solvatochromic fluorescent naphthalimides: design, synthesis, photophysical properties and fluorescence switch-on sensing of ct-DNA.
Bag SS; Pradhan MK; Kundu R; Jana S
Bioorg Med Chem Lett; 2013 Jan; 23(1):96-101. PubMed ID: 23206865
[TBL] [Abstract][Full Text] [Related]
5. Colorimetric and fluorescent anion sensors: an overview of recent developments in the use of 1,8-naphthalimide-based chemosensors.
Duke RM; Veale EB; Pfeffer FM; Kruger PE; Gunnlaugsson T
Chem Soc Rev; 2010 Oct; 39(10):3936-53. PubMed ID: 20818454
[TBL] [Abstract][Full Text] [Related]
6. Remarkable DNA binding affinity and potential anticancer activity of pyrrolo[2,1-c][1,4]benzodiazepine-naphthalimide conjugates linked through piperazine side-armed alkane spacers.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2008 Aug; 16(15):7218-24. PubMed ID: 18656370
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the groove binding mechanism of a biocompatible naphthalimide-based organoselenocyanate with calf thymus DNA: an "ex vivo" fluorescence imaging application appended by biophysical experiments and molecular docking simulations.
Mati SS; Roy SS; Chall S; Bhattacharya S; Bhattacharya SC
J Phys Chem B; 2013 Nov; 117(47):14655-65. PubMed ID: 24205834
[TBL] [Abstract][Full Text] [Related]
8. 1,8-Naphthalimide: A Potent DNA Intercalator and Target for Cancer Therapy.
Tandon R; Luxami V; Kaur H; Tandon N; Paul K
Chem Rec; 2017 Oct; 17(10):956-993. PubMed ID: 28375569
[TBL] [Abstract][Full Text] [Related]
9. Lysosomes-targeting imaging and anticancer properties of novel bis-naphthalimide derivatives.
Rong RX; Wang SS; Liu X; Li RF; Wang KR; Cao ZR; Li XL
Bioorg Med Chem Lett; 2018 Feb; 28(4):742-747. PubMed ID: 29342415
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent organometallic rhodium(I) and ruthenium(II) metallodrugs with 4-ethylthio-1,8-naphthalimide ligands: Antiproliferative effects, cellular uptake and DNA-interaction.
Streciwilk W; Terenzi A; Cheng X; Hager L; Dabiri Y; Prochnow P; Bandow JE; Wölfl S; Keppler BK; Ott I
Eur J Med Chem; 2018 Aug; 156():148-161. PubMed ID: 30006161
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, DNA Binding, and Anticancer Properties of Bis-Naphthalimide Derivatives with Lysine-Modified Polyamine Linkers.
Huang Y; Wu CX; Song Y; Huang M; Tian DN; Yang XB; Fan YR
Molecules; 2018 Jan; 23(2):. PubMed ID: 29382135
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence properties and antiproliferative effects of mono-, bis-, and tris- thiophenylnaphthalimides: results of a comparative pilot study.
Ott I; Xu Y; Qian X
J Photochem Photobiol B; 2011 Oct; 105(1):75-80. PubMed ID: 21839647
[TBL] [Abstract][Full Text] [Related]
13. The novel anti-tumor agents of 4-triazol-1,8-naphthalimides: synthesis, cytotoxicity, DNA intercalation and photocleavage.
Li X; Lin Y; Wang Q; Yuan Y; Zhang H; Qian X
Eur J Med Chem; 2011 Apr; 46(4):1274-9. PubMed ID: 21345546
[TBL] [Abstract][Full Text] [Related]
14. Molecular design, chemical synthesis, and biological evaluation of '4-1' pentacyclic aryl/heteroaryl-imidazonaphthalimides.
Li F; Cui J; Guo L; Qian X; Ren W; Wang K; Liu F
Bioorg Med Chem; 2007 Aug; 15(15):5114-21. PubMed ID: 17532640
[TBL] [Abstract][Full Text] [Related]
15. 5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior.
Xie L; Cui J; Qian X; Xu Y; Liu J; Xu R
Bioorg Med Chem; 2011 Jan; 19(2):961-7. PubMed ID: 21208805
[TBL] [Abstract][Full Text] [Related]
16. Sulfur-substituted naphthalimides as photoactivatable anticancer agents: DNA interaction, fluorescence imaging, and phototoxic effects in cultured tumor cells.
Ott I; Xu Y; Liu J; Kokoschka M; Harlos M; Sheldrick WS; Qian X
Bioorg Med Chem; 2008 Aug; 16(15):7107-16. PubMed ID: 18644732
[TBL] [Abstract][Full Text] [Related]
17. Naphthalimide-based macrophage nucleus imaging probes.
Fueyo-González F; Fernández-Gutiérrez M; García-Puentes D; Orte A; González-Vera JA; Herranz R
Eur J Med Chem; 2020 Aug; 200():112407. PubMed ID: 32512480
[TBL] [Abstract][Full Text] [Related]
18. 4-Amino-1,8-naphthalimide-based Tröger's bases as high affinity DNA targeting fluorescent supramolecular scaffolds.
Veale EB; Frimannsson DO; Lawler M; Gunnlaugsson T
Org Lett; 2009 Sep; 11(18):4040-3. PubMed ID: 19681640
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, G-Quadruplex DNA binding and cytotoxic properties of naphthalimide substituted styryl dyes.
Wang MQ; Liao YF; Zhang SH; Yu QQ; Huang JQ
Bioorg Med Chem; 2020 Mar; 28(5):115325. PubMed ID: 31982241
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and fluorescence of the new environment-sensitive fluorophore 6-chloro-2,3-naphthalimide derivative.
Katritzky AR; Ozcan S; Todadze E
Org Biomol Chem; 2010 Mar; 8(6):1296-300. PubMed ID: 20204199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
